Armon Sharei

2022

In 2022, Armon Sharei earned a total compensation of $2.7M as Former Chief Executive Officer at SQZ Biotechnologies Co, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$276,808
Option Awards$1,829,706
Salary$550,000
Other$47,960
Total$2,704,474

Sharei received $1.8M in option awards, accounting for 68% of the total pay in 2022.

Sharei also received $276.8K in non-equity incentive plan, $550K in salary and $48K in other compensation.

Rankings

In 2022, Armon Sharei's compensation ranked 1,360th out of 5,760 executives tracked by ExecPay. In other words, Sharei earned more than 76.4% of executives.

ClassificationRankingPercentile
All
1,360
out of 5,760
76th
Division
Manufacturing
669
out of 3,136
79th
Major group
Chemicals And Allied Products
247
out of 1,422
83rd
Industry group
Drugs
226
out of 1,323
83rd
Industry
Biological Products, Except Diagnostic Substances
57
out of 291
80th
Source: SEC filing on April 26, 2023.

Sharei's colleagues

We found four more compensation records of executives who worked with Armon Sharei at SQZ Biotechnologies Co in 2022.

2022

Howard Bernstein

SQZ Biotechnologies Co

Chief Executive Officer

2022

Micah Zajic

SQZ Biotechnologies Co

Chief Financial Officer

2022

Lawrence Knopf

SQZ Biotechnologies Co

General Counsel

2022

Marshelle Warren

SQZ Biotechnologies Co

Chief Medical Officer

News

In-depth

You may also like